New
Pharmaceutical name: Proviron 25
Manufacturer: Sterling Knight Pharmaceutical
Package: 60 tablets, each tablet contains 25mg Mesterolone
Active Substance: Mesterolone
Proviron 25 is indicated for the treatment of axillary node- negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection and breast irradiation.
This product is no longer in stock
Availability date:
Pharmaceutical name: Proviron 25
Manufacturer: Sterling Knight Pharmaceutical
Package: 60 tablets, each tablet contains 25mg Mesterolone
Active Substance: Mesterolone
Proviron 25 is indicated for the treatment of axillary node- negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection and breast irradiation.
Presentation 60 tablets, each tablet contains 25mg Mesterolone
Protection
hologram with serial NO and verification code